Dr. Reddy's Laboratories Ltd — Cash Flow (NYSE:RDY) | MetaTrader

Open full chart

Financials

Overview Statement Statistics Dividends

Quarterly Annual

Cash from operating activities 488 M370 M716 M545 M545 M607 M — Cash from investing activities -310 M-348 M-503 M-483 M-682 M700 M — Cash from financing activities -4 M-32 M-327 M-45 M222 M88 M — Free cash flow 488 M370 M716 M545 M545 M607 M —

News

Dr. Reddy's Laboratories Limited (RDY) Discusses Manufacturing Issue and Process Review for Semaglutide Transcript

India: From Generics Giant To Innovation Powerhouse?

Dr. Reddy's Launches Generic Semaglutide In Canada, Expands GLP-1 Push - Dr Reddy's Laboratories (NYSE:RD

Dr. Reddy's Q4 Earnings and Revenues Miss Estimates, Stock Down

Dr. Reddy's Laboratories Limited (RDY) Q4 2026 Earnings Call Transcript

AMPH vs. RDY: Which Stock Should Value Investors Buy Now?

AMRX Valuation: What 1.69x Sales Means for Investors

India's Generic Wave Hits Ozempic And Wegovy As Prices Drop Sharply - Novo Nordisk (NYSE:NVO)

India Is Great, But Be Careful When Everyone Agrees With The Thesis (BATS:INDA)

ESPR's Q4 Earnings Lag Estimates, Revenues Beat, Stock Down

Zacks Industry Outlook Highlights Teva Pharmaceuticals, Sandoz and Dr. Reddy's

3 Generic Drug Stocks to Watch Despite Industry Headwinds